GERD (acid reflux) Board decisions

The Board remands the Veteran's claim for service connection for GERD to correct a pre-decisional duty to assist error, as the December 2023 examination was found inadequate.

The Board denied the Veteran's appeal for an initial disability rating in excess of 30 percent for his service-connected GERD, as the evidence did not support a higher rating.

The Board denied service connection for type II diabetes, peripheral neuropathy of the bilateral upper and lower extremities, GERD, liver cancer, heart disability, skin cancer, sinusitis, and a heart disability on the basis that there was no evidence to support an in-service incurrence or continuity of symptomatology since service.

The Board granted eligibility for the direct payment of attorney fees based on 20 percent of past due benefits awarded in a May 2023 rating decision, but denied entitlement to additional fees.

The Board granted service connection for gastroesophageal reflux disease and chronic epididymitis, but remanded the claim for motion sickness due to missing service treatment records.

The Board denied service connection for multiple conditions, including a right elbow disability, digestive disorder other than GERD, dizziness/vertigo disorder, STD, skin disorders of the toes and face, ears, neck, and jawline.

The Board remands the claims for service connection for erectile dysfunction, GERD, Barret's Esophagus, and a hiatal hernia due to inadequate VA examinations and opinions.

The Board remands the claim for service connection for GERD to obtain a TERA opinion due to potential participation in a toxic exposure risk activity during military service.

The Board remands the issue of entitlement to service connection for an esophageal condition, to include GERD, due to an inadequate medical opinion.

The Board denied ratings in excess of 50 percent for chronic sinusitis, 10 percent for tinnitus, and 30 percent for cervical strain. It granted an initial rating of at least 10 percent for right tibia fracture residuals effective January 26, 2018, and at least 20 percent effective June 2, 2021. The Board remanded several other issues including secondary service connection claims.

The Board remands the claim for service connection for gastroesophageal reflux disease (GERD) to request an addendum medical opinion.

The Board granted an initial rating of 30 percent for GERD, effective July 3, 2019.

The appeal for an earlier effective date and higher rating for GERD, as well as the appeal for service connection for degenerative joint disease of the right shoulder, were dismissed due to a duplicate stream issue.

The Board denied a rating in excess of 10 percent for the Veteran's GERD, finding that the evidence did not support a higher rating under either the old or new criteria.

The Board granted service connection for hypertension and congestive heart failure, but denied service connection for a gastrointestinal disorder. The issue of an acquired psychiatric disorder was remanded.

The Board granted service connection for gastritis and right ear hearing loss, reopened on new and material evidence. The claims for a stomach condition (GERD, gastritis, gastric polyp) and right ear hearing loss were remanded for further development.

The Board denied increased ratings for PTSD and GERD, remanded claims related to degenerative disc disease of the lumbar spine, left shoulder strain, chronic fatigue syndrome, Parkinson's disease, self-inflicted scarring, dystonia, and TDIU.

The Board denied the veteran's appeal for an increased rating for gastroesophageal reflux disease (GERD), finding that the severity of the condition most closely approximated the criteria for a 10 percent disability evaluation.

The Board denied service connection for diabetes mellitus and remanded the claims for obstructive sleep apnea and gastroesophageal reflux disease (GERD) for further development.

The Board denied increased ratings for GERD, right and left hip strains, as well as service connection for a left ankle disability and obstructive sleep apnea (OSA).